The Hypersensitive Esophagus: Pathophysiology, Evaluation, and Treatment Options.

11:09 EDT 27th August 2014 | BioPortfolio

Summary of "The Hypersensitive Esophagus: Pathophysiology, Evaluation, and Treatment Options."

Visceral hypersensitivity plays a key role in the pathogenesis of esophageal functional disorders such as functional heartburn and chest pain of presumed esophageal origin (noncardiac chest pain). About 80% of patients with unexplained noncardiac chest pain exhibit lower esophageal sensory thresholds when compared to controls during esophageal sensory testing (ie, esophageal barostat, impedance planimetry). Such information has led to prescription of peripherally and/or centrally acting therapies for the management of these patients. This review summarizes and highlights recent and significant findings regarding the pathophysiology, evaluation, and treatment of the hypersensitive esophagus, a central factor in functional esophageal disorders.

Affiliation

Laboratorio de Fisiologia Digestiva y Motilidad Gastrointestinal, Instituto de Investigaciones Medico Biologicas, Iturbide s/n, Col. Flores Magon, Veracruz, Veracruz, CP 91400, Mexico, joremes@uv.mx.

Journal Details

This article was published in the following journal.

Name: Current gastroenterology reports
ISSN: 1534-312X
Pages:

Links

PubMed Articles [23548 Associated PubMed Articles listed on BioPortfolio]

Advances in the Treatment of Achalasia.

Achalasia, although rare, remains one of the most commonly diagnosed disorders of esophageal motility. It results from an idiopathic loss of ganglion cells responsible for esophageal motility and rela...

Evaluation and Management of Post-Transurethral Resection of the Prostate Lower Urinary Tract Symptoms.

Transurethral resection of the prostate (TURP) continues to be the most common treatment in the operative management of benign prostatic hypertrophy (BPH). Several other modalities have shown equivale...

New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.

"Refractory GERD" is one the most common misnomers in the area of gastroesophageal reflux disease. The term implies reflux as the underlying etiology despite unresponsiveness to aggressive, often twic...

Multiple primary cancers of the esophagus and hepatocellular carcinoma-a report of 4 cases.

Esophageal cancer (EC) often occurs synchronously or metachronously with other primary cancers; however, the occurrence of multiple primary cancers (MPC) of the esophagus and hepatocellular carcinoma...

Treatment Options for Covert Hepatic Encephalopathy.

The main issue with treating covert hepatic encephalopathy (HE) is to establish whether it is cost effective to reverse the neuropsychiatric abnormalities that define this mild form of HE. Until fairl...

Clinical Trials [1845 Associated Clinical Trials listed on BioPortfolio]

Familial Barrett's Esophagus

This is a multi-center study whose aim is to define the epidemiology and genetics of Barrett's esophagus and adenocarcinoma. The researchers have studied families affected with Barrett's e...

Study of Endoscopic Barrett's Esophagus Diagnosis

Barrett's esophagus (BE) is a condition that often occurs in patients who have had GERD for a long time. The researchers are interested in BE because it can sometimes become a cancer in t...

Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer

The purpose of this study is to confirm the effectiveness and safety of a new medical device which sprays liquid nitrogen through an upper endoscope (cryotherapy) to treat Barrett's esopha...

Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus

Patients with Barrett's Esophagus are known to have excessive distal esophageal acid exposure comparable to patients with erosive esophagitis. A significant proportion of patients with BE...

Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation

As the left atrium is in close vicinity to the esophagus, radiofrequency ablation in the left atrium may damage the esophagus and create esophageal perforations and esophageal left atrial...

Medical and Biotech [MESH] Definitions

A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).

Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.

Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.

A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.

Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.

Search BioPortfolio: